Decreased Expression of miR-125b and miR-100 in Oral Cancer Cells Contributes to Malignancy

被引:192
作者
Henson, Brian J. [1 ]
Bhattacharjee, Samsiddhi [1 ]
O'Dee, Dawn M. [2 ]
Feingold, Eleanor [1 ,3 ]
Gollin, Susanne M. [1 ,4 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA
关键词
GROWTH-FACTOR RECEPTOR-3; MICRORNA EXPRESSION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; 11Q13; AMPLICON; OVARIAN-CANCER; T-LYMPHOCYTES; HEAD; CARCINOMA; NECK;
D O I
10.1002/gcc.20666
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Altered microRNA (miRNA) expression profiles have been observed in numerous malignancies, including oral squamous cell carcinoma (OSCC). However, their role in disease is not entirely clear. Several genetic aberrations are characteristic of OSCC, with amplification of chromosomal band 11q13 and loss of distal 11q being among the most prevalent. It is not known if the expression levels of miRNAs in these regions are altered or whether they play a role in disease. We hypothesize that the expression of miRNAs mapping to 11q are altered in OSCC because of loss or amplification of chromosomal material, and that this contributes to the development and progression of OSCC. We found that miR-125b and miR-100 are down-regulated in OSCC tumor and cell lines, and that transfecting cells with exogenous miR-125b and miR-100 significantly reduced cell proliferation and modified the expression of target and nontarget genes, including some that are over-expressed in radioresistant OSCC cells. In conclusion, the down-regulation of miR-125b and miR-100 in OSCC appears to play an important role in the development and/or progression of disease and may contribute to the loss of sensitivity to ionizing radiation. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:569 / 582
页数:14
相关论文
共 88 条
[11]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[12]   MicroRNA-cancer connection: The beginning of a new tale [J].
Calin, George Adrian ;
Croce, Carlo Maria .
CANCER RESEARCH, 2006, 66 (15) :7390-7394
[13]   Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression [J].
Chiang, WC ;
Wong, YK ;
Lin, SC ;
Chang, KW ;
Liu, CJ .
ORAL DISEASES, 2006, 12 (01) :27-33
[14]   In situ expression of IFN-γ-inducible T cell α chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression [J].
Chu, Yiwei ;
Yang, Xiuli ;
Xu, Wei ;
Wang, Ying ;
Guo, Qiang ;
Xiong, Sidong .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (10) :1539-1549
[15]   Processing of primary microRNAs by the Microprocessor complex [J].
Denli, AM ;
Tops, BBJ ;
Plasterk, RHA ;
Ketting, RF ;
Hannon, GJ .
NATURE, 2004, 432 (7014) :231-235
[16]   Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis [J].
Fong, S ;
Itahana, Y ;
Sumida, T ;
Singh, J ;
Coppe, JP ;
Liu, Y ;
Richards, PC ;
Bennington, JL ;
Lee, NM ;
Debs, RJ ;
Desprez, PY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13543-13548
[17]  
Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO
[18]  
2-H
[19]  
Gómez-Román JJ, 2005, CLIN CANCER RES, V11, P459
[20]  
Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022